Novartis sees 20 per cent profit rise
The Swiss pharmaceutical group, Novartis, has posted record-breaking net profits of SFr1.79 billion ($1.1 billion) for the first quarter, a 20 per cent rise on the previous year.
This content was published on April 18, 2002 - 08:28
According to a company statement, revenue also increased by 10 per cent, to SFr7.8 billon, compared to SFr7.22 for the same period last year.
swissinfo with agencies
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here. Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.